Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with a two-tiered therapeutic interchange policy.

D S Rich1

  • 1Department of Pharmacy, University Hospital, Boston University Medical Center, MA 02118.

American Journal of Hospital Pharmacy
|September 1, 1989
PubMed
Summary

This study shows a two-tiered therapeutic interchange policy can cut drug costs. Pharmacists can switch some drugs automatically, while others require prescriber approval, improving cost-effectiveness and physician acceptance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated medication distribution systems and compliance with Joint Commission standards.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2002
Same author

Changes in home care accreditation: enhancing patient care at alternative sites.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

Effects of age, sex, race, diagnosis-related group, and hospital setting on lipid management in patients with coronary artery disease.

The American journal of cardiology·2000
Same author

Integrating Oryx into a home care organization's performance-improvement program.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Same author

A process for interpreting data on adverse drug events: determining optimal target levels.

Clinical therapeutics·1999
Same author

On accreditation of healthcare organizations. Determining eligibility for Accreditation of Home Pharmaceutical Services.

Home care provider·1996

Area of Science:

  • Health Economics
  • Pharmacology
  • Hospital Pharmacy Management

Background:

  • University hospitals implement formulary policies for therapeutic interchange to manage drug costs.
  • A two-tiered approach allows routine interchanges for some drugs and requires prescriber contact for others.
  • Class representatives are designated for non-formulary drugs, with pharmacy able to change them based on price.

Purpose of the Study:

  • To evaluate the impact of a two-tiered therapeutic interchange policy on drug costs and prescribing patterns for histamine H2-receptor antagonists.
  • To assess the feasibility and acceptance of therapeutic interchange by physicians and pharmacists.

Main Methods:

  • Selection of a class representative for injectable histamine H2-receptor antagonists, considering past experiences with therapeutic equivalence.
  • Implementation steps included cost analysis, literature review, expert consultation, committee presentation, bidding, and staff education.
  • Analysis of prescribing data for both injectable and oral H2 antagonists before and after policy implementation.

Main Results:

  • Prescribing shifted from ranitidine to cimetidine as the designated class representative for injectable H2 antagonists (84% to 90%).
  • Similar shifts were observed for oral H2 antagonists.
  • Total hospital costs for H2 antagonists decreased by 8.4% within one year.

Conclusions:

  • A two-tiered therapeutic interchange policy effectively reduces drug costs.
  • This approach expands the range of drugs considered therapeutic equivalents acceptably to physicians and pharmacists.
  • The policy demonstrates a successful strategy for optimizing formulary management and cost savings.

Related Experiment Videos